Lijnen HR - Search Results

1

Generation of a stable activated thrombin activable fibrinolysis inhibitor variant.

Ceresa E, Van de Borne K, Peeters M, Lijnen HR, Declerck PJ, Gils A. Ceresa E, et al. Among authors: lijnen hr. J Biol Chem. 2006 Jun 9;281(23):15878-83. doi: 10.1074/jbc.M509839200. Epub 2006 Apr 4. J Biol Chem. 2006. PMID: 16595693 Free article.

2

Inactivation of plasminogen activator inhibitor-1 by specific proteolysis with stromelysin-1 (MMP-3).

Lijnen HR, Arza B, Van Hoef B, Collen D, Declerck PJ. Lijnen HR, et al. J Biol Chem. 2000 Dec 1;275(48):37645-50. doi: 10.1074/jbc.M006475200. J Biol Chem. 2000. PMID: 10967118 Free article.

3

The hyperfibrinolytic state of mice with combined thrombin-activatable fibrinolysis inhibitor (TAFI) and plasminogen activator inhibitor-1 gene deficiency is critically dependent on TAFI deficiency.

Vercauteren E, Peeters M, Hoylaerts MF, Lijnen HR, Meijers JC, Declerck PJ, Gils A. Vercauteren E, et al. Among authors: lijnen hr. J Thromb Haemost. 2012 Dec;10(12):2555-62. doi: 10.1111/jth.12036. J Thromb Haemost. 2012. PMID: 23083123 Free article.

4

Characterization of a panel of monoclonal antibodies toward mouse PAI-1 that exert a significant profibrinolytic effect in vivo.

Van De Craen B, Scroyen I, Abdelnabi R, Brouwers E, Lijnen HR, Declerck PJ, Gils A. Van De Craen B, et al. Among authors: lijnen hr. Thromb Res. 2011 Jul;128(1):68-76. doi: 10.1016/j.thromres.2011.01.011. Epub 2011 Mar 9. Thromb Res. 2011. PMID: 21392818

5

Maximal PAI-1 inhibition in vivo requires neutralizing antibodies that recognize and inhibit glycosylated PAI-1.

Van De Craen B, Scroyen I, Vranckx C, Compernolle G, Lijnen HR, Declerck PJ, Gils A. Van De Craen B, et al. Among authors: lijnen hr. Thromb Res. 2012 Apr;129(4):e126-33. doi: 10.1016/j.thromres.2011.11.038. Epub 2011 Dec 16. Thromb Res. 2012. PMID: 22178065

6

Role of alpha 2-antiplasmin in fibrin-specific clot lysis with single-chain urokinase-type plasminogen activator in human plasma.

Declerck PJ, Lijnen HR, Verstreken M, Collen D. Declerck PJ, et al. Among authors: lijnen hr. Thromb Haemost. 1991 Apr 8;65(4):394-8. Thromb Haemost. 1991. PMID: 2057921

7

A monoclonal antibody specific for two-chain urokinase-type plasminogen activator. Application to the study of the mechanism of clot lysis with single-chain urokinase-type plasminogen activator in plasma.

Declerck PJ, Lijnen HR, Verstreken M, Moreau H, Collen D. Declerck PJ, et al. Among authors: lijnen hr. Blood. 1990 May 1;75(9):1794-800. Blood. 1990. PMID: 1691934 Free article.

8

Bio-immunoassay for staphylokinase in blood.

Lijnen HR, Beelen V, Declerck PJ, Collen D. Lijnen HR, et al. Thromb Haemost. 1993 Sep 1;70(3):491-4. Thromb Haemost. 1993. PMID: 8259555

9

Biochemical and functional characterization of human tissue-type plasminogen activator variants with mutagenized kringle domains.

Collen D, Lijnen HR, Bulens F, Vandamme AM, Tulinsky A, Nelles L. Collen D, et al. Among authors: lijnen hr. J Biol Chem. 1990 Jul 25;265(21):12184-91. J Biol Chem. 1990. PMID: 2115513 Free article.

10

Recombinant staphylokinase variants with altered immunoreactivity. I: Construction and characterization.

Collen D, Bernaerts R, Declerck P, De Cock F, Demarsin E, Jenné S, Laroche Y, Lijnen HR, Silence K, Verstreken M. Collen D, et al. Among authors: lijnen hr. Circulation. 1996 Jul 15;94(2):197-206. doi: 10.1161/01.cir.94.2.197. Circulation. 1996. PMID: 8674179

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

381 results

Search Page

Filters